Clinical Trial Update: SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the use of SGLT2 inhibitors for adult primary nephrotic syndrome, covering Phase 2 and Phase 3, sponsored by Mansoura University; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• SGLT2 inhibitors (class)

Snippet

Sponsor: Mansoura University | Conditions: Nephrotic Syndrome | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING